These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 1424419)
1. Influence of lansoprazole treatment on diazepam plasma concentrations. Lefebvre RA; Flouvat B; Karolac-Tamisier S; Moerman E; Van Ganse E Clin Pharmacol Ther; 1992 Nov; 52(5):458-63. PubMed ID: 1424419 [TBL] [Abstract][Full Text] [Related]
2. Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole. Andersson T; Cederberg C; Edvardsson G; Heggelund A; Lundborg P Clin Pharmacol Ther; 1990 Jan; 47(1):79-85. PubMed ID: 2104790 [TBL] [Abstract][Full Text] [Related]
3. Lack of pharmacokinetic interaction after administration of lansoprazole or omeprazole with prednisone. Cavanaugh JH; Karol MD J Clin Pharmacol; 1996 Nov; 36(11):1064-71. PubMed ID: 8973995 [TBL] [Abstract][Full Text] [Related]
4. Lack of pharmacokinetic interaction between lansoprazole and intravenously administered phenytoin. Karol MD; Locke CS; Cavanaugh JH J Clin Pharmacol; 1999 Dec; 39(12):1283-9. PubMed ID: 10586395 [TBL] [Abstract][Full Text] [Related]
5. Lack of pharmacokinetic interaction of pantoprazole with diazepam in man. Gugler R; Hartmann M; Rudi J; Brod I; Huber R; Steinijans VW; Bliesath H; Wurst W; Klotz U Br J Clin Pharmacol; 1996 Aug; 42(2):249-52. PubMed ID: 8864328 [TBL] [Abstract][Full Text] [Related]
6. Effect of omeprazole and cimetidine on plasma diazepam levels. Andersson T; Andrén K; Cederberg C; Edvardsson G; Heggelund A; Lundborg P Eur J Clin Pharmacol; 1990; 39(1):51-4. PubMed ID: 2276389 [TBL] [Abstract][Full Text] [Related]
7. Lack of interaction between lansoprazole and propranolol, a pharmacokinetic and safety assessment. Karol MD; Locke CS; Cavanaugh JH J Clin Pharmacol; 2000 Mar; 40(3):301-8. PubMed ID: 10709160 [TBL] [Abstract][Full Text] [Related]
8. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects. Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212 [TBL] [Abstract][Full Text] [Related]
9. Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole. Hussein Z; Granneman GR; Mukherjee D; Samara E; Hogan DL; Koss MA; Isenberg JI Br J Clin Pharmacol; 1993 Nov; 36(5):391-8. PubMed ID: 12959285 [TBL] [Abstract][Full Text] [Related]
10. The effects of lansoprazole, 30 or 60 mg daily, on intragastric pH and on endocrine function in healthy volunteers. Dammann HG; von zur Mühlen A; Balks HJ; Damaschke A; Steinhoff J; Hennig U; Schwarz JA; Fuchs W Aliment Pharmacol Ther; 1993 Apr; 7(2):191-6. PubMed ID: 8485272 [TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects. Doan TT; Wang Q; Griffin JS; Lukasik NL; O'Dea RF; Pan WJ Am J Health Syst Pharm; 2001 Aug; 58(16):1512-9. PubMed ID: 11515348 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation. Ishizaki T; Chiba K; Manabe K; Koyama E; Hayashi M; Yasuda S; Horai Y; Tomono Y; Yamato C; Toyoki T Clin Pharmacol Ther; 1995 Aug; 58(2):155-64. PubMed ID: 7648765 [TBL] [Abstract][Full Text] [Related]
13. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers. Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W Digestion; 1995; 56(2):137-44. PubMed ID: 7750667 [TBL] [Abstract][Full Text] [Related]
14. Rapid effect of lansoprazole on intragastric pH: a crossover comparison with omeprazole. Thoring M; Hedenström H; Eriksson LS Scand J Gastroenterol; 1999 Apr; 34(4):341-5. PubMed ID: 10365892 [TBL] [Abstract][Full Text] [Related]
15. Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19. Shimatani T; Inoue M; Kuroiwa T; Xu J; Mieno H; Nakamura M; Tazuma S Clin Pharmacol Ther; 2006 Jan; 79(1):144-52. PubMed ID: 16413249 [TBL] [Abstract][Full Text] [Related]
16. Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration. Brummer RJ; Geerling BJ; Stockbrügger RW Dig Dis Sci; 1997 Oct; 42(10):2132-7. PubMed ID: 9365148 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic interaction between acetaminophen and lansoprazole. Sanaka M; Kuyama Y; Mineshita S; Qi J; Hanada Y; Enatsu I; Tanaka H; Makino H; Yamanaka M J Clin Gastroenterol; 1999 Jul; 29(1):56-8. PubMed ID: 10405233 [TBL] [Abstract][Full Text] [Related]
18. Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve. Niioka T; Yasui-Furukori N; Uno T; Sugawara K; Kaneko S; Tateishi T Ther Drug Monit; 2006 Jun; 28(3):321-5. PubMed ID: 16778714 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children. Tran A; Rey E; Pons G; Pariente-Khayat A; D'Athis P; Sallerin V; Dupont C Clin Pharmacol Ther; 2002 May; 71(5):359-67. PubMed ID: 12011821 [TBL] [Abstract][Full Text] [Related]
20. Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously. Freston J; Chiu YL; Pan WJ; Lukasik N; Täubel J Am J Gastroenterol; 2001 Jul; 96(7):2058-65. PubMed ID: 11467632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]